CStone Pharmaceuticals has secured FDA clearance for its investigational new drug application, allowing the launch of a Phase II trial of CS2009, a trispecific antibody that simultaneously targets PD‑1, VEGFA and CTLA‑4. The global study uses a parallel, multi‑cohort expansion design with 15 cohorts across nine solid‑tumour indications, including cervical, small‑cell lung, gastric, ovarian and triple‑negative breast cancers. Recruitment is underway in the United States, China and Australia, building on Phase I safety and anti‑tumour data collected since the first dose in March 2025. The trial will evaluate CS2009 as monotherapy and in combination regimens, with dose optimisation and expansion strategies aligned with FDA feedback.
ExCellThera and its subsidiary Cordex Biologics have secured a Status 1 listing under Germany’s NUB programme for their cell therapy Zemcelpro (dorocubicel). The therapy, which received conditional marketing authorisation from the European Commission, targets adults with haematological malignancies lacking suitable donor...

China’s pharmaceutical sector is rapidly expanding, now generating its own GLP‑1 drugs alongside imported treatments. Novo Nordisk reported a 5% decline in Ozempic sales in China last year, the first dip since its 2021 launch, while sales grew elsewhere. The...

Danaher, a US healthcare conglomerate, is close to finalizing a roughly $10 billion acquisition of Masimo, the maker of pulse‑oximetry and other medical monitoring devices. The deal, still subject to antitrust clearance, would add Masimo’s sensor technology to Danaher’s Life Sciences...
Biopharma faces a tightening fetal bovine serum (FBS) market as U.S. cattle inventories hit record lows and European disease outbreaks curb supply. Prices have surged more than 300% over five years and release timelines have lengthened from weeks to months...
A University of Utah Health study examined red‑light photobiomodulation (PBM) as a preventive therapy for repetitive head acceleration events in collegiate football. Twenty‑six Division I athletes were randomized to active or sham transcranial and intranasal PBM over 16 weeks, receiving three...

Paras Health has appointed Balkishan Sharma as chief human resources and business transformation officer, a move that underscores the network’s drive toward operational excellence and growth. Sharma returns after a six‑year stint with the group and brings more than 18...
Radiology societies, led by the Society of Interventional Radiology, have asked Cigna to reverse policy 0539, which labels implantable peripheral nerve stimulation (PNS) for chronic pain as medically unnecessary. The groups cite robust randomized trials, FDA clearance, and a favorable...
Livingston HealthCare in Montana announced that its phone system has been fully restored after a recent cybersecurity incident forced the hospital to shut down communications and other network services. The disruption, first reported on Feb. 13, stemmed from a potential...

A new preprint analyzing fMRI data from 1,286 participants aged 8‑100 finds that sex differences in brain connectivity are minimal in childhood but expand sharply at puberty and continue diverging into adulthood. Using an AI model called Krakencoder, researchers identified...
HFMA’s FastFinance podcast highlights new off‑campus HOPD reporting requirements that could impose significant cost burdens on health systems. The episode also cites a "Weird Number"—a 3‑5% annual net revenue loss attributed to inefficient electronic health records and billing platforms. Additionally,...

Smart hospital rooms equipped with interactive displays, sensors, and AI are moving from pilot projects to core infrastructure in new builds and retrofits. The global market, valued at $67 billion in 2024, is expected to nearly triple by 2030 as health...
Effective Jan. 1 2028, the Consolidated Appropriations Act of 2026 requires hospitals to assign separate NPIs and submit two provider‑based attestations for each off‑campus hospital outpatient department (HOPD) or lose Medicare OPPS reimbursement. Compliance documentation can be extensive—up to 200 pages per...
Dr. Michael Spaeder will present at HIMSS26 on using AI‑enabled analysis of continuous bedside cardiorespiratory monitoring to detect patient deterioration earlier than traditional electronic health record methods. He will contrast predictive insights from live physiologic data with retrospective EHR analytics,...
The FDA granted accelerated approval to sibeprenlimab‑szsi (Voyxact) for primary IgA nephropathy, marking the first APRIL‑inhibiting monoclonal antibody for this condition. Interim results from the phase 3 VISIONARY trial showed a 50 % reduction in proteinuria at nine months versus 2 % with...
AdventHealth President and CEO David Banks will deliver the opening keynote at HIMSS26’s Executive Summit in Las Vegas, titled “Leading Through Healthcare’s Perfect Storm.” He will frame the current systemic headwinds as an opportunity to shift from episodic, diagnosis‑centric care to...

Andreessen Horowitz (a16z) led a $2.3 million pre‑seed round in Swedish AI dental startup Dentio, marking the firm’s first bite into Sweden’s health‑tech ecosystem. The investment follows a16z’s broader strategy of deploying scouts and partners across Europe to capture early‑stage AI...

Healthcare faces a looming shortage of over 63,000 full‑time registered nurses by 2030, intensifying pressure on existing staff. Manual tasks such as charting and medication administration divert nurses from bedside care, prompting a push for smarter automation. Omnicell’s new Titan...

Healthcare leaders traditionally separate emotion from decision‑making, but a recent hospital closure in New York demonstrates that compassionate leadership can coexist with operational rigor. The tertiary medical center reduced from 700 to 200 beds, faced financial loss, and ultimately closed...

Federal policies driven by Health Secretary Robert F. Kennedy Jr. are creating a hostile environment for vaccine developers, prompting companies like Moderna to scale back late‑stage studies. A Texas startup canceled a new manufacturing plant, and a San Diego firm...
Medicare Advantage insurers are confronting a perfect storm of rising medical costs and a flat payment increase of less than 1% announced by CMS for 2026. The new risk‑adjustment formula and stagnant reimbursement fall below the medical‑cost trend, compressing margins...

Dr. Mehmet Oz, CMS administrator, advocated AI avatars as the most effective solution to bridge mental‑health gaps in rural America. He highlighted the chronic shortage of clinicians and argued that agentic AI can conduct early intakes, detect subtle speech cues,...
Carroll County, Maryland launched a Whole Blood Program in May, enabling paramedics to carry and transfuse 500‑ml Type O‑positive units on scene. The initiative has saved 14 lives and been used 17 times, with 100% survival for internal hemorrhage cases...
Prime Healthcare conducted a nine‑month, 13‑hospital trial of two virtual sitter models—an integrated turnkey vendor and a split‑component approach—to enhance patient safety in Phase 2 of its virtual care strategy. The integrated model, which supplies hardware, software, and remote observers, outperformed...
The fourth quarter of 2025 marked the first quarter‑over‑quarter rise in biopharma job postings, with a 10% increase and a 4% uptick in average listings, despite a 14% year‑over‑year decline. Science/research and development roles grew 14% while clinical positions surged...
The article traces the shifting terminology of digital health records, noting that the "electronic health record" (EHR) label gained popularity during the Bush 43 era while earlier versions were called CPR and later EMR. It argues the rebranding served vendor pricing...

Direct‑to‑consumer advertising for prescription drugs is resurging, highlighted by Novo Nordisk’s $180 million spend on Ozempic TV spots in 2022 and $189 million in 2023. The ads use upbeat jingles and lifestyle imagery to present the GLP‑1 medication as a gateway to...
A pragmatic randomized trial in the southeastern US tested a 12‑month produce‑prescription program that gave diabetes patients at risk of food insecurity an $80 monthly debit card for fruits and vegetables. After enrolling 2,155 participants, the intervention showed no significant...
Medicare announced a sweeping transition to value‑based care, extending bundled‑payment and quality‑adjusted reimbursement models to virtually all Medicare‑eligible services. The initiative introduces new performance metrics that link payments directly to patient outcomes, with quarterly reporting requirements for participating providers. Early...
At HIMSS26, Greg O'Neill, director of Patient & Family Health Education at ChristianaCare, presented a session titled “A Prescription to End Confusion.” The talk highlighted a new organizational goal to boost health literacy across clinical workflows. O'Neill explained how clearer...
On Jan 2026 the FDA issued updated guidance that relaxes oversight for low‑risk digital health products, including many AI‑enabled clinical decision support tools and consumer wellness wearables. The guidance clarifies which software falls outside the medical device definition, allowing these tools...

Virtual reality (VR) therapy shows rapid clinical effects but remains confined to pilot studies due to a lack of standardized dosage protocols. Researchers highlight wide variation in session length, frequency, and content across studies, preventing reliable comparison and scaling. The...

The article examines a proposed federal framework that would shift health‑affordability dollars into individual‑controlled accounts, highlighting that ownership of the payment infrastructure will decide market winners. It points to the rapid growth of high‑deductible plans, Health Savings Accounts exceeding $100 billion,...
Researchers at the University of Tokyo applied a machine‑learning tool, AI‑IR, to estimate insulin resistance in half a million UK Biobank participants. The analysis revealed insulin resistance as a significant risk factor for twelve distinct cancer types, providing the first...
Roche announced that its anti‑CD20 antibody Gazyva (obinutuzumab) met the primary endpoint in the phase 3 MAJESTY trial for primary membranous nephropathy (pMN). The study showed significantly higher complete remission rates at two years compared with the immunosuppressant tacrolimus, while maintaining...

Cardiovascular disease remains the top U.S. killer, driven by the intertwined cardiovascular‑kidney‑metabolic (CKM) syndrome that links obesity, diabetes, and chronic kidney disease. About one‑third of adults carry three or more CKM risk factors, and 90% meet early‑stage criteria. Monogram Health’s...
Richard Pazdur, longtime FDA oncology leader, resigned after being pressured to endorse a controversial policy that would reduce required drug approval trials from two to one. He said Commissioner Marty Makary breached the traditional independence between the commissioner’s office and...

César de la Fuente’s Penn team is using artificial intelligence to scour genomes for antimicrobial peptides, creating a library of over one million candidate sequences. The AI has uncovered promising molecules hidden in archaea, venomous species, and even extinct organisms...
A recent national study of 2,300 women aged 21‑65 found that 60.8% still prefer clinician‑collected cervical cancer screening over FDA‑approved at‑home self‑collection kits. While 20.4% expressed interest in home testing, the majority’s preference signals that traditional Pap and HPV specimens...
Novartis released final Phase III ALIGN data showing its oral endothelin‑A antagonist Vanrafia (atrasentan) slowed kidney function decline in adults with IgA nephropathy. The double‑blind, placebo‑controlled trial enrolled 340 biopsy‑confirmed patients who continued optimized RAS inhibition, delivering a 2.39 ml/min/1.73 m² advantage in...
Medtronic has secured FDA clearance for its Stealth AXiS spine‑surgery robotics platform, an integrated solution that combines robotics, planning and navigation in a single workflow. The system features LiveAlign segmental tracking, delivering real‑time visualization of anatomical movement and reducing the need...
Researchers at the AITHYRA Institute introduced a high‑throughput chemical diversification platform that systematically creates molecular‑glue candidates and screens them directly in living cells. Applying the workflow to the leukemia‑associated protein ENL, they identified a small molecule that selectively induces ENL...

Brainomix unveiled its next‑generation Brainomix 360 Stroke platform at the International Stroke Conference, featuring an industry‑first net water uptake (NWU) metric derived from routine non‑contrast CT scans. The platform earned the Red Dot Design Award, highlighting its superior usability and innovative...

VISIE Inc. announced the launch of its Partner APIs, a robot‑agnostic interface that brings the company’s spatial computing and real‑time scanning capabilities to surgical robotics platforms. Built on gRPC and supporting multiple programming languages, the APIs deliver scanner control, object...

TechRadar’s Graham reviews Sentai, a UK‑made AI voice companion built for seniors living independently. The speaker delivers reminders, medication prompts, and conversational companionship while deliberately avoiding constant listening or surveillance. In testing, Sentri handled emotional cues, emergency alerts, and privacy...
The Royal Marsden NHS Foundation Trust has successfully delivered online adaptive radiotherapy (oART) using an existing Elekta linear accelerator, demonstrating that high‑precision treatment can be achieved without dedicated machines. The system adapts the radiation plan in real time, reducing safety...
Researchers introduced a microneedle patch (MN‑Mg) that simultaneously delivers hydrogen gas and magnesium ions directly into the injured spinal cord. The hydrogen component rapidly scavenges reactive oxygen species, cutting oxidative stress by roughly 55%, while the magnesium release sustains microglial...
The European Commission will launch a call for proposals on 21 April 2026 to fund two large‑scale pilots that deploy cloud‑based AI and generative AI for medical imaging, allocating €9 million under the Digital Europe Programme. The pilots target real‑world clinical settings,...
Researchers have created piezoelectric nerve guidance conduits (NGCs) that incorporate zinc oxide nanoparticles and multidimensional oriented structures. The conduits are fabricated by merging digital light processing (DLP) 3D printing with directional freezing, producing channels and micropores that align regenerating axons....

Google’s AI Overviews, which appear atop search results, provide health answers without an upfront safety disclaimer. The only warning—"For informational purposes only"—shows after users click the “Show more” button and is rendered in a smaller, lighter font. Experts say this...